Welcome Packet
Been diagnosed or want to learn more?
Request a Packet
About Duchenne
Facts, Treatment, and Care
Read More
Duchenne News
The latest from our partners.
Read Now
Transition Resources
GotTransition resources and tools.
Learn More
Community Ambassadors
Meet our Community Ambassadors
Read Now
Clinical Trials
A quick look at investigational drug studies
Read More
Female Carriers
Resources, Care, and Programs
Learn More
Connect with our Carrier Specialist
Get support and help navigating your journey
Meet Trina
Carrier Conversations
Join a carrier support group session.
Upcoming Events
Volunteer Opportunities
Ways to get involved and help raise funds and awareness for Duchenne.
Volunteer Today
Community Ambassadors
These ambassadors are Jett Foundation’s extra ears, eyes, and voice.
Team Jett
Activate your muscles at events to raise awareness and funds for the Duchenne community.
Join Team Jett
Become a Partner
Learn about creating a partnership and joining our community.
Get Started
Host a Webinar
Learn about our community webinar series.
View Upcoming Webinars
Resource Library
Read about our resources for Partners.
Resources for Partners
How To Help
Make a difference in the lives of those living with Duchenne.
Get Started Volunteering
Clinical Trials
A quick look at investigational drug studies.
Read More About Clinical Trials
Duchenne News
Stay up to date with the latest discoveries.
Read Now
Dan and DMD & Other Books
These books will help parents, guardians, and individuals as they navigate a Duchenne diagnosis and journey.
Read Here
Our Insurance Flight Plan
Our Health Insurance Flight Plan breaks down options that may be available to you.
Download the Flight Plan
Resource Library
Read about our resources for Medical Professionals.
Resources for Medical Professionals
Please join Jett Foundation and Astellas for a webinar to discuss the Phase 1b clinical trial studying ASP0367 in Duchenne muscular dystrophy. The trial is enrolling boys ages 8 to 16 years old who are taking a stable dose of steroids and have difficulty walking, regardless of mutation type.
ASP0367 is an oral investigational drug being tested in DMD. We will describe ASP0367, the clinical trial design, endpoints, inclusion and exclusion criteria, and other details about the trial.
Read their community letter for more information regarding ASP0367
Ha Tran, MD, MS, FAAP
Senior Medical Director
Global Medical Lead
Astellas Pharma
Ha Tran, MD, MS, FAAP is a Senior Medical Director and Global Medical Lead at Astellas Pharma US where her work focuses on mitochondrial and pediatric diseases. She is a board certified Pediatrician, specializing in Pediatric Nephrology, an Adjunct Clinical Assistant Professor at Stanford School of Medicine in the Department of Pediatrics. Dr. Tran has successfully led clinical trials in both medical devices and pharmaceuticals across various phases, in adults, children, and rare diseases.
Jett Foundation invites all members of the Duchenne community to attend our Community Webinar Series! This series is focused on topics tailored to help individuals and families impacted by Duchenne learn more about care, clinical trials, resources, and support. We are committed to providing these 1-hour presentations to empower individuals and families with the tools and resources needed to be their own best advocates.
View Our Upcoming Educational Webinars
Please contact [email protected] with any questions or if you’d like to become a future speaker at one of our community webinars. We look forward to having you participate in these virtual community engagement events!
Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!
Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.